Both in Pharmaceuticals
Processa Pharmaceuticals vs Longeveron
Over the past year PCSA returned −78.7% and LGVN returned −80.1%; their daily moves had a correlation of 0.04.
PCSA −78.7% LGVN −80.1%Growth of $1, one year, split-adjusted
| Metric | PCSA | LGVN |
|---|---|---|
| Price | $1.89 | $1.67 |
| Market cap | $5.3M | $5.3M |
| Today | 0.00% | −4.57% |
| 1 month | +16.7% | −35.5% |
| 6 months | −25.9% | −80.4% |
| Year to date | −34.4% | −67.0% |
| 1 year | −80.6% | −81.2% |
| Revenue growth (YoY) | — | −9.2% |
| Gross margin | — | 63.4% |
| Net margin | — | −2116.0% |
| P/E (TTM) | — | — |
| Price / sales | — | 4.5× |
| Net cash | $196.3K | $10.1M |
| Dividend yield | — | — |
| Volatility (60d) | 90.1% | 708.6% |
| Short % of float | 2.0% | 2.8% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).